Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.73%175.23T | 11.89%46.62T | 4.73%42.93T | 6.60%45.02T | 7.65%40.66T | 14.43%162.66T | 9.23%41.67T | 8.71%40.99T | 17.31%42.23T | 24.66%37.77T |
Operating revenue | 7.73%175.23T | 11.89%46.62T | 4.73%42.93T | 6.60%45.02T | 7.65%40.66T | 14.43%162.66T | 9.23%41.67T | 8.71%40.99T | 17.31%42.23T | 24.66%37.77T |
Cost of revenue | 7.98%139.48T | 12.67%37.54T | 5.85%34.43T | 5.84%35.28T | 7.44%32.23T | 13.43%129.18T | 9.57%33.32T | 7.18%32.53T | 16.56%33.34T | 22.32%30T |
Gross profit | 6.76%35.75T | 8.79%9.09T | 0.41%8.5T | 9.43%9.74T | 8.45%8.43T | 18.44%33.48T | 7.89%8.35T | 15.03%8.46T | 20.24%8.9T | 34.61%7.77T |
Operating expense | 17.17%21.51T | 26.70%6.26T | 6.09%4.92T | 17.38%5.46T | 17.96%4.87T | -0.49%18.36T | 12.96%4.94T | -20.16%4.63T | 5.19%4.65T | 7.40%4.13T |
Selling and administrative expenses | 19.61%13.94T | 34.56%4.09T | 1.30%3T | 20.84%3.65T | 21.56%3.2T | -8.28%11.66T | 10.66%3.04T | -32.44%2.97T | -0.90%3.02T | 4.20%2.63T |
-Selling and marketing expense | 23.79%11.64T | 45.79%3.45T | 0.08%2.47T | 24.39%3.04T | 26.13%2.66T | -11.70%9.4T | 20.26%2.37T | -37.60%2.47T | -5.08%2.45T | -1.18%2.11T |
-General and administrative expense | 2.20%2.31T | -5.31%631.48B | 7.38%532.64B | 5.71%606.99B | 3.01%535.84B | 9.31%2.26T | -13.80%666.92B | 14.86%496.02B | 21.97%574.19B | 33.79%520.21B |
Research and development costs | 9.71%2.37T | 13.79%716.29B | 9.55%607.97B | 9.06%570.31B | 5.01%478.91B | 22.94%2.16T | 6.99%629.47B | 28.14%554.96B | 33.88%522.94B | 31.18%456.09B |
Operating profit | -5.87%14.24T | -17.18%2.82T | -6.47%3.58T | 0.73%4.28T | -2.33%3.56T | 53.96%15.13T | 1.29%3.41T | 146.71%3.83T | 42.57%4.25T | 88.83%3.64T |
Net non-operating interest income expense | 20.67%539.61B | -19.35%135.44B | -0.50%120.58B | 59.60%153B | 112.77%133.05B | 317.43%447.19B | 294.45%167.94B | 289.37%121.18B | 425.14%95.86B | 288.67%62.53B |
Non-operating interest income | -1.69%980.76B | -10.19%243.03B | -9.63%235.21B | 4.88%255.66B | 10.70%246.86B | 67.93%997.66B | 59.88%270.62B | 44.61%260.28B | 76.13%243.76B | 109.54%223B |
Non-operating interest expense | -19.02%451.5B | 7.46%117.93B | -17.58%114.64B | -30.58%102.66B | -27.69%116.27B | 6.52%557.53B | -32.73%109.75B | -6.56%139.09B | 23.10%147.89B | 76.22%160.8B |
Total other finance cost | -46.38%-10.34B | ---- | ---- | ---- | -656.79%-2.45B | 80.63%-7.06B | ---- | ---- | ---- | 64.43%-324M |
Other net income (expense) | ||||||||||
Special income (charges) | 31.00%-275.39B | 27.81%-85.52B | -101.43%-101.75B | 73.95%-43.95B | 28.06%-44.17B | -84.53%-399.12B | -104.41%-118.48B | -94.84%-50.51B | -280.45%-168.74B | 30.27%-61.39B |
-Less:Other special charges | -31.00%275.39B | -27.81%85.52B | 101.43%101.75B | -73.95%43.95B | -28.06%44.17B | 84.53%399.12B | 104.41%118.48B | 94.84%50.51B | 280.45%168.74B | -30.27%61.39B |
Other non- operating income (expenses) | 26.84%-171.04B | -446.80%-397.04B | 57.52%92.42B | 134.21%79.53B | 327.33%54.06B | -743.72%-233.8B | 64.68%-72.61B | -60.77%58.67B | -1,313.72%-232.5B | 37.41%12.65B |
Income before tax | 0.92%17.78T | -4.27%3.12T | -7.22%4.37T | 11.22%5.57T | 1.73%4.73T | 57.57%17.62T | 9.62%3.26T | 130.63%4.71T | 28.69%5T | 103.93%4.65T |
Income tax | -8.52%4.23T | 7.80%644.75B | -14.91%1.16T | -6.52%1.39T | -11.93%1.03T | 55.30%4.63T | -42.68%598.12B | 116.93%1.37T | 85.20%1.49T | 133.80%1.17T |
Net income | 7.80%13.23T | 12.33%2.47T | -2.95%3.21T | 24.71%4.17T | -1.27%3.38T | 53.72%12.27T | 28.81%2.2T | 134.04%3.3T | 8.49%3.35T | 92.38%3.42T |
Net income continuous Operations | 4.29%13.55T | -6.99%2.47T | -4.07%3.21T | 18.73%4.17T | 6.34%3.7T | 58.39%12.99T | 37.92%2.66T | 136.75%3.34T | 13.96%3.52T | 95.50%3.47T |
Net income discontinuous operations | 55.66%-319.11B | --0 | ---- | ---- | -475.61%-319.11B | -229.11%-719.72B | ---457.35B | ---38.3B | ---168.64B | ---55.44B |
Minority interest income | 126.42%703.22B | 948.96%193.82B | 40.88%160.28B | 82.56%204.07B | 34.48%145.05B | -49.85%310.58B | -510.02%-22.83B | -18.65%113.77B | -60.27%111.78B | -43.95%107.86B |
Net income attributable to the parent company | 4.72%12.53T | 2.47%2.28T | -4.52%3.05T | 22.71%3.97T | -2.43%3.23T | 62.43%11.96T | 30.58%2.23T | 150.83%3.19T | 15.39%3.24T | 108.94%3.31T |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 4.72%12.53T | 2.47%2.28T | -4.52%3.05T | 22.71%3.97T | -2.43%3.23T | 62.43%11.96T | 30.58%2.23T | 150.83%3.19T | 15.39%3.24T | 108.94%3.31T |
Basic earnings per share | 4.18%23.81K | 0.53%4.28K | -4.66%5.8K | 22.27%7.55K | -2.98%6.14K | 60.24%22.85K | 29.98%4.26K | 147.07%6.09K | 13.60%6.17K | 106.39%6.33K |
Diluted earnings per share | 4.18%23.81K | 0.53%4.28K | -4.66%5.8K | 22.27%7.55K | -2.98%6.14K | 60.24%22.85K | 29.98%4.26K | 147.07%6.09K | 13.60%6.17K | 106.39%6.33K |
Dividend per share | -47.33%2.93K | 0 | 22.21%934.2868 | 35.76%1.01K | 985.4348 | 5.57K | 4.06K | 764.4862 | 745.253 | 0 |
Currency Unit | KRW | KRW | KRW | KRW | KRW | KRW | KRW | KRW | KRW | KRW |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |